English
简体中文
Total: £ 56.28
Published Date: 2024-11-05 | Pages: 70 | Tables: 139 | Medical Care
"High-end Cellomics" is a term that combines "high-end" technology with "cellomics," which refers to the study of cellular components and functions using advanced imaging and analysis techniques. In the context of high-end cellomics, it typically refers to the use of sophisticated and advanced technologies for cellular analysis, imaging, and high-content screening.
The global market for High-end Cellomics was estimated to be worth US$ 294 million in 2023 and is forecast to a readjusted size of US$ 487.7 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030
North American market for High-end Cellomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for High-end Cellomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for High-end Cellomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of High-end Cellomics include PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation and Merck, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for High-end Cellomics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of High-end Cellomics by region & country, by Type, and by Application.
The High-end Cellomics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High-end Cellomics.
Market Segmentation
By Company
PerkinElmer, Inc.
Thermo Fisher Scientific, Inc.
Danaher Corporation
Merck
Segment by Type:
Basic Research
Drug Discovery
Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Independent Contract Research Organizations (CROs)
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of High-end Cellomics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of High-end Cellomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of High-end Cellomics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 High-end Cellomics Product Introduction
1.2 Global High-end Cellomics Market Size Forecast
1.3 High-end Cellomics Market Trends & Drivers
1.3.1 High-end Cellomics Industry Trends
1.3.2 High-end Cellomics Market Drivers & Opportunity
1.3.3 High-end Cellomics Market Challenges
1.3.4 High-end Cellomics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global High-end Cellomics Players Revenue Ranking (2023)
2.2 Global High-end Cellomics Revenue by Company (2019-2024)
2.3 Key Companies High-end Cellomics Manufacturing Base Distribution and Headquarters
2.4 Key Companies High-end Cellomics Product Offered
2.5 Key Companies Time to Begin Mass Production of High-end Cellomics
2.6 High-end Cellomics Market Competitive Analysis
2.6.1 High-end Cellomics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by High-end Cellomics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High-end Cellomics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Basic Research
3.1.2 Drug Discovery
3.2 Global High-end Cellomics Sales Value by Type
3.2.1 Global High-end Cellomics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global High-end Cellomics Sales Value, by Type (2019-2030)
3.2.3 Global High-end Cellomics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical & Biotechnology Companies
4.1.2 Academic & Research Institutes
4.1.3 Independent Contract Research Organizations (CROs)
4.2 Global High-end Cellomics Sales Value by Application
4.2.1 Global High-end Cellomics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global High-end Cellomics Sales Value, by Application (2019-2030)
4.2.3 Global High-end Cellomics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global High-end Cellomics Sales Value by Region
5.1.1 Global High-end Cellomics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global High-end Cellomics Sales Value by Region (2019-2024)
5.1.3 Global High-end Cellomics Sales Value by Region (2025-2030)
5.1.4 Global High-end Cellomics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America High-end Cellomics Sales Value, 2019-2030
5.2.2 North America High-end Cellomics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe High-end Cellomics Sales Value, 2019-2030
5.3.2 Europe High-end Cellomics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific High-end Cellomics Sales Value, 2019-2030
5.4.2 Asia Pacific High-end Cellomics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America High-end Cellomics Sales Value, 2019-2030
5.5.2 South America High-end Cellomics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa High-end Cellomics Sales Value, 2019-2030
5.6.2 Middle East & Africa High-end Cellomics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions High-end Cellomics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions High-end Cellomics Sales Value
6.3 United States
6.3.1 United States High-end Cellomics Sales Value, 2019-2030
6.3.2 United States High-end Cellomics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States High-end Cellomics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe High-end Cellomics Sales Value, 2019-2030
6.4.2 Europe High-end Cellomics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe High-end Cellomics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China High-end Cellomics Sales Value, 2019-2030
6.5.2 China High-end Cellomics Sales Value by Type (%), 2023 VS 2030
6.5.3 China High-end Cellomics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan High-end Cellomics Sales Value, 2019-2030
6.6.2 Japan High-end Cellomics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan High-end Cellomics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea High-end Cellomics Sales Value, 2019-2030
6.7.2 South Korea High-end Cellomics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea High-end Cellomics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia High-end Cellomics Sales Value, 2019-2030
6.8.2 Southeast Asia High-end Cellomics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia High-end Cellomics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India High-end Cellomics Sales Value, 2019-2030
6.9.2 India High-end Cellomics Sales Value by Type (%), 2023 VS 2030
6.9.3 India High-end Cellomics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 PerkinElmer, Inc.
7.1.1 PerkinElmer, Inc. Profile
7.1.2 PerkinElmer, Inc. Main Business
7.1.3 PerkinElmer, Inc. High-end Cellomics Products, Services and Solutions
7.1.4 PerkinElmer, Inc. High-end Cellomics Revenue (US$ Million) & (2019-2024)
7.1.5 PerkinElmer, Inc. Recent Developments
7.2 Thermo Fisher Scientific, Inc.
7.2.1 Thermo Fisher Scientific, Inc. Profile
7.2.2 Thermo Fisher Scientific, Inc. Main Business
7.2.3 Thermo Fisher Scientific, Inc. High-end Cellomics Products, Services and Solutions
7.2.4 Thermo Fisher Scientific, Inc. High-end Cellomics Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Scientific, Inc. Recent Developments
7.3 Danaher Corporation
7.3.1 Danaher Corporation Profile
7.3.2 Danaher Corporation Main Business
7.3.3 Danaher Corporation High-end Cellomics Products, Services and Solutions
7.3.4 Danaher Corporation High-end Cellomics Revenue (US$ Million) & (2019-2024)
7.3.5 Merck Recent Developments
7.4 Merck
7.4.1 Merck Profile
7.4.2 Merck Main Business
7.4.3 Merck High-end Cellomics Products, Services and Solutions
7.4.4 Merck High-end Cellomics Revenue (US$ Million) & (2019-2024)
7.4.5 Merck Recent Developments
8 Industry Chain Analysis
8.1 High-end Cellomics Industrial Chain
8.2 High-end Cellomics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 High-end Cellomics Sales Model
8.5.2 Sales Channel
8.5.3 High-end Cellomics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. High-end Cellomics Market Trends
Table 2. High-end Cellomics Market Drivers & Opportunity
Table 3. High-end Cellomics Market Challenges
Table 4. High-end Cellomics Market Restraints
Table 5. Global High-end Cellomics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global High-end Cellomics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies High-end Cellomics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies High-end Cellomics Product Type
Table 9. Key Companies Time to Begin Mass Production of High-end Cellomics
Table 10. Global High-end Cellomics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High-end Cellomics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global High-end Cellomics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global High-end Cellomics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global High-end Cellomics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global High-end Cellomics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global High-end Cellomics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global High-end Cellomics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global High-end Cellomics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global High-end Cellomics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global High-end Cellomics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global High-end Cellomics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global High-end Cellomics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global High-end Cellomics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global High-end Cellomics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global High-end Cellomics Sales Value by Region (2019-2024) & (%)
Table 27. Global High-end Cellomics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions High-end Cellomics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions High-end Cellomics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions High-end Cellomics Sales Value, (2025-2030) & (US$ Million)
Table 31. PerkinElmer, Inc. Basic Information List
Table 32. PerkinElmer, Inc. Description and Business Overview
Table 33. PerkinElmer, Inc. High-end Cellomics Products, Services and Solutions
Table 34. Revenue (US$ Million) in High-end Cellomics Business of PerkinElmer, Inc. (2019-2024)
Table 35. PerkinElmer, Inc. Recent Developments
Table 36. Thermo Fisher Scientific, Inc. Basic Information List
Table 37. Thermo Fisher Scientific, Inc. Description and Business Overview
Table 38. Thermo Fisher Scientific, Inc. High-end Cellomics Products, Services and Solutions
Table 39. Revenue (US$ Million) in High-end Cellomics Business of Thermo Fisher Scientific, Inc. (2019-2024)
Table 40. Thermo Fisher Scientific, Inc. Recent Developments
Table 41. Danaher Corporation Basic Information List
Table 42. Danaher Corporation Description and Business Overview
Table 43. Danaher Corporation High-end Cellomics Products, Services and Solutions
Table 44. Revenue (US$ Million) in High-end Cellomics Business of Danaher Corporation (2019-2024)
Table 45. Danaher Corporation Recent Developments
Table 46. Merck Basic Information List
Table 47. Merck Description and Business Overview
Table 48. Merck High-end Cellomics Products, Services and Solutions
Table 49. Revenue (US$ Million) in High-end Cellomics Business of Merck (2019-2024)
Table 50. Merck Recent Developments
Table 51. Key Raw Materials Lists
Table 52. Raw Materials Key Suppliers Lists
Table 53. High-end Cellomics Downstream Customers
Table 54. High-end Cellomics Distributors List
Table 55. Research Programs/Design for This Report
Table 56. Key Data Information from Secondary Sources
Table 57. Key Data Information from Primary Sources
Table 58. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. High-end Cellomics Product Picture
Figure 2. Global High-end Cellomics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global High-end Cellomics Sales Value (2019-2030) & (US$ Million)
Figure 4. High-end Cellomics Report Years Considered
Figure 5. Global High-end Cellomics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by High-end Cellomics Revenue in 2023
Figure 7. High-end Cellomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Basic Research Picture
Figure 9. Drug Discovery Picture
Figure 10. Global High-end Cellomics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global High-end Cellomics Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Pharmaceutical & Biotechnology Companies
Figure 13. Product Picture of Academic & Research Institutes
Figure 14. Product Picture of Independent Contract Research Organizations (CROs)
Figure 15. Global High-end Cellomics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global High-end Cellomics Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America High-end Cellomics Sales Value (2019-2030) & (US$ Million)
Figure 18. North America High-end Cellomics Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe High-end Cellomics Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe High-end Cellomics Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific High-end Cellomics Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific High-end Cellomics Sales Value by Country (%), 2023 VS 2030
Figure 23. South America High-end Cellomics Sales Value (2019-2030) & (US$ Million)
Figure 24. South America High-end Cellomics Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa High-end Cellomics Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa High-end Cellomics Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions High-end Cellomics Sales Value (%), (2019-2030)
Figure 28. United States High-end Cellomics Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States High-end Cellomics Sales Value by Type (%), 2023 VS 2030
Figure 30. United States High-end Cellomics Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe High-end Cellomics Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe High-end Cellomics Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe High-end Cellomics Sales Value by Application (%), 2023 VS 2030
Figure 34. China High-end Cellomics Sales Value, (2019-2030) & (US$ Million)
Figure 35. China High-end Cellomics Sales Value by Type (%), 2023 VS 2030
Figure 36. China High-end Cellomics Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan High-end Cellomics Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan High-end Cellomics Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan High-end Cellomics Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea High-end Cellomics Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea High-end Cellomics Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea High-end Cellomics Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia High-end Cellomics Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia High-end Cellomics Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia High-end Cellomics Sales Value by Application (%), 2023 VS 2030
Figure 46. India High-end Cellomics Sales Value, (2019-2030) & (US$ Million)
Figure 47. India High-end Cellomics Sales Value by Type (%), 2023 VS 2030
Figure 48. India High-end Cellomics Sales Value by Application (%), 2023 VS 2030
Figure 49. High-end Cellomics Industrial Chain
Figure 50. High-end Cellomics Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
